DAP3
Basic information
Region (hg38): 1:155687960-155739010
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DAP3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 18 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 18 | 4 | 1 |
Variants in DAP3
This is a list of pathogenic ClinVar variants found in the DAP3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-155688070-C-A | Grange syndrome | Likely pathogenic (Mar 26, 2024) | ||
1-155688077-G-A | Likely pathogenic (Nov 16, 2022) | |||
1-155688080-G-A | Benign (Dec 31, 2019) | |||
1-155688099-A-G | Benign (Dec 31, 2019) | |||
1-155688109-G-A | Inborn genetic diseases | Uncertain significance (Apr 17, 2024) | ||
1-155688110-A-G | Benign/Likely benign (May 01, 2024) | |||
1-155688140-G-A | Inborn genetic diseases | Uncertain significance (Feb 28, 2024) | ||
1-155688145-C-T | Benign (Dec 31, 2019) | |||
1-155688191-G-A | Inborn genetic diseases | Uncertain significance (May 27, 2022) | ||
1-155688195-A-T | YY1AP1-related disorder | Likely benign (Aug 14, 2019) | ||
1-155688218-AGAG-A | Grange syndrome | Uncertain significance (Feb 16, 2018) | ||
1-155688221-G-A | Inborn genetic diseases | Uncertain significance (Jun 06, 2023) | ||
1-155688224-G-A | YY1AP1-related disorder | Likely benign (Dec 31, 2019) | ||
1-155688235-T-C | Inborn genetic diseases | Likely benign (Oct 14, 2023) | ||
1-155688239-G-A | Inborn genetic diseases | Uncertain significance (Dec 18, 2023) | ||
1-155688244-A-T | Pathogenic (Nov 25, 2017) | |||
1-155688259-G-A | Inborn genetic diseases | Uncertain significance (Sep 14, 2022) | ||
1-155688262-G-A | Inborn genetic diseases | Uncertain significance (Apr 12, 2023) | ||
1-155688269-A-G | Inborn genetic diseases • YY1AP1-related disorder | Benign/Likely benign (Jun 21, 2023) | ||
1-155688285-T-C | Likely benign (Jul 10, 2017) | |||
1-155688290-T-C | Inborn genetic diseases | Uncertain significance (Mar 08, 2024) | ||
1-155688292-G-T | Inborn genetic diseases | Uncertain significance (Feb 06, 2024) | ||
1-155688300-T-TC | Pathogenic (Sep 08, 2017) | |||
1-155688320-GGCGGCGGCA-G | YY1AP1-related disorder | Benign (Dec 31, 2019) | ||
1-155688323-G-A | Inborn genetic diseases | Uncertain significance (Oct 26, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DAP3 | protein_coding | protein_coding | ENST00000368336 | 12 | 51051 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.11e-9 | 0.532 | 125703 | 0 | 45 | 125748 | 0.000179 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.311 | 206 | 219 | 0.941 | 0.0000116 | 2616 |
Missense in Polyphen | 38 | 52.212 | 0.72781 | 633 | ||
Synonymous | 0.127 | 78 | 79.4 | 0.982 | 0.00000420 | 746 |
Loss of Function | 1.17 | 17 | 23.1 | 0.737 | 0.00000108 | 274 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00114 | 0.00113 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000545 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000151 | 0.000149 |
Middle Eastern | 0.0000545 | 0.0000544 |
South Asian | 0.000167 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in mediating interferon-gamma-induced cell death.;
- Pathway
- Mitochondrial translation initiation;Translation;Metabolism of proteins;Mitochondrial translation elongation;Mitochondrial translation termination;Mitochondrial translation;TRAIL signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- loftool
- 0.970
- rvis_EVS
- -0.22
- rvis_percentile_EVS
- 37.43
Haploinsufficiency Scores
- pHI
- 0.263
- hipred
- N
- hipred_score
- 0.394
- ghis
- 0.590
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.799
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dap3
- Phenotype
- cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; growth/size/body region phenotype; embryo phenotype;
Gene ontology
- Biological process
- mitochondrial translational elongation;mitochondrial translational termination;apoptotic signaling pathway
- Cellular component
- nucleoplasm;mitochondrion;mitochondrial inner membrane;mitochondrial small ribosomal subunit
- Molecular function
- RNA binding;structural constituent of ribosome;protein binding;GTP binding